Replies to post #15286 on GTC Biotherapeutics (fka GTCB)

[jessellivermore]

Good post

I just Emailed Dr. Cox a question about why they have not been able to enact cost reductions,,,, wish you would have posted this 15 min ago

[vinmantoo]

Dew,

I was just throwing out a ballpark number. However, I find it hard to believe that they can't cut 5% or 10% now, by salary reduction for executives and even laying off some of them. I would expect a good managment would do cutting after the LFB deal passes in order to stretch out the cash as long as possible.

I do agree that the wasted time after rATIII approval in Europe is far more damning. Even worse in my view is that the DIC trial wasn't made the major priority for GTCB, and that they let LEO waste so much time. I mean it is GTCB's only approved drug and the potential market dwarfs HD. They should have been making LEO's life miserable by continually pressing them. As far as DIC, I think it the phase II DIC shows some really good data in phase II, that will be a real positive since the market is so large.